Received May 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | UNK | — | — |
HCP reports she has a 38 year old patient who previously received 2 doses of the GARDASIL series about 18-20 years ago. The patient missed her 3rd dose of GARDASIL and did not complete the vaccine series. No further details. No additional AE/ No PQC.; No additional AE; This spontaneous report was received from a healthcare professional (reported as a certified midwife) regarding a 38-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On unknown dates (reported as about 18-20 years ago), the patient was vaccinated with the first and second doses of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL), administered as prophylaxis (strengths, doses, routes of administration, anatomical sites of injection, lot numbers and expiration dates were not reported for any dose). The reporter stated that the patient missed her third dose of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) and did not complete the vaccine series (Inappropriate schedule of product administration). No additional adverse events were reported.